Weekly Digest – November 2025 Weekly Digest – November 2025 04 November 2025: MSD enters into research and development funding agreement with Blackstone Life Sciences for Sacituzumab tirumotecan (sac-TMT) MSD announced a $700 million strategic financing agreement with Blackstone Life […]
Weekly Digest – November 2025 Weekly Digest – November 2025 05 November 2025: ABL Bio subsidiary Neok Bio officially launches in the US, accelerating development of dual antibody ADCs ABL Bio officially launched its U.S.-based subsidiary Neok Bio, focused on […]
Weekly Digest – November 2025 Weekly Digest – November 2025 31 October 2025: Mycenax and RIN sign license agreement to advance ADC development using RIN’s proprietary linker technology Mycenax Biotech Inc., a Taiwan-based biologics CDMO, entered into a License Agreement […]
Weekly Digest – November 2025 Weekly Digest – November 2025 31 October 2025: IntoCell and Xcellon Biologics partner to expand access to next-generation ADC technologies Xcellon Biologics, a leading ADC-focused CDMO, has entered into a partnership with IntoCell Inc. to […]
Weekly Digest – November 2025 Weekly Digest – November 2025 31 October 2025: Ajinomoto Inc enters licensing agreement with Astellas Pharma for biopharmaceutical development and manufacturing technology Ajinomoto Co., Inc. has entered into a licensing agreement with Astellas Pharma Inc. […]
